Brief: Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety
04/06/2024 13:47
June 4 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA SUBMITS PRE-INVESTIGATIONAL NEW DRUG
APPLICATION TO
FDA FOR SPC-15 AS A TREATMENT FOR PTSD AND ANXIETY
* SILO PHARMA-IN ACCORDANCE WITH SPONSORED RESEARCH DEAL, CO
TO BE
GRANTED EXCLUSIVE LICENSE TO FURTHER DEVELOP,COMMERCIALIZE
SPC-15 WORLDWIDE
Source text for Eikon: ID:nGNXLCRph
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement